US Broker Ratings

PROCEPT BioRobotics (PRCT) Stock Analysis: A 30.87% Potential Upside in the Healthcare Robotics Market

PROCEPT BioRobotics Corporation (NASDAQ: PRCT) stands as a cutting-edge leader in the medical devices sector, specifically within the realm of surgical robotics. Headquartered in San Jose, California, the company has..

89bio, Inc. (ETNB) Stock Analysis: Eyeing a 194.55% Upside Potential

For investors with an appetite for high-risk, high-reward opportunities, 89bio, Inc. (NASDAQ: ETNB) presents an intriguing prospect within the biotechnology sector. Headquartered in San Francisco, this clinical-stage biopharmaceutical company is..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Unpacking the 25% Potential Upside in the Healthcare Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT) stands out in the healthcare sector with a unique focus on developing, manufacturing, and marketing medical devices for vascular surgery. With a market capitalization of..

Amicus Therapeutics, Inc. (FOLD) Stock Analysis: A Potential 177% Upside in the Biotech Sector

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is making waves in the biotechnology sector with its focus on rare diseases. This Princeton, New Jersey-based company is attracting significant attention from investors, particularly..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Exploring a 138% Potential Upside Amidst Innovative Vaccine Developments

Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company based in Emeryville, California, presents a riveting investment opportunity in the healthcare sector. With a market capitalization of $1.17 billion, Dynavax specializes..

Arcellx, Inc. (ACLX) Stock Analysis: Biotechnology Innovator with a Robust 74.68% Potential Upside

Arcellx, Inc. (NASDAQ: ACLX) is capturing attention with its ambitious strides in the biotechnology sector, particularly in the field of cancer immunotherapy. Specializing in developing innovative treatment options for cancers..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Biotech Contender with a 29% Upside Potential

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is capturing investor attention with its promising pipeline in the biotechnology sector, particularly in the realm of peptide therapeutics for hematology, blood disorders, inflammatory, and..

Neogen Corporation (NEOG) Stock Analysis: Exploring an 88.68% Potential Upside

Neogen Corporation (NASDAQ: NEOG), a prominent player in the healthcare sector’s Diagnostics & Research industry, has recently caught the attention of investors, with an exciting 88.68% potential upside based on..

Evotec SE (EVO) Stock Analysis: Unveiling a 58% Potential Upside Amidst Strategic Collaborations

Evotec SE (EVO), a notable player in the healthcare sector, is making waves in the drug manufacturing industry with its innovative approach and global partnerships. Based in Germany, Evotec operates..

AtriCure, Inc. (ATRC) Stock Analysis: Unveiling a 56% Potential Upside with Strong Buy Consensus

AtriCure, Inc. (NASDAQ: ATRC) is making waves in the healthcare sector, particularly in the medical instruments and supplies industry. With a robust market capitalization of $1.58 billion, AtriCure has carved..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: A Biotech Gem with Nearly 91% Upside Potential

For investors seeking opportunities in the healthcare sector, ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) presents a compelling case, especially with its nearly 91% potential upside based on current analyst ratings. As..

GRAIL, Inc. (GRAL) Investor Outlook: Navigating a -26.86% Potential Downside with Healthcare Innovation

Investors eyeing GRAIL, Inc. (NASDAQ: GRAL) should prepare for a journey through the challenging yet potentially rewarding landscape of healthcare diagnostics and research. With a current market capitalization of $1.55..

Amedisys Inc (AMED) Stock Analysis: Evaluating Market Position Amidst Modest Revenue Growth

Amedisys Inc (AMED), a key player in the healthcare sector, specifically within the medical care facilities industry, is capturing investor attention with its strategic focus on home health, hospice, and..

Catalyst Pharmaceuticals (CPRX) Stock Analysis: Biotech’s 55% Upside Potential Captures Investor Attention

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) stands out in the biotechnology sector with its focus on rare diseases, offering a compelling proposition for investors. With a market capitalization of $2.7 billion,..

Omnicell, Inc. (OMCL) Stock Analysis: Healthcare Tech Pioneer with a 40% Upside Potential

Omnicell, Inc. (NASDAQ: OMCL), a leader in health information services, stands out as a compelling investment opportunity in the healthcare sector. With a market capitalization of $1.33 billion, Omnicell specializes..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring a 17.20% Potential Upside Amidst Challenging Metrics

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a leading player in the healthcare sector specializing in medical instruments and supplies, has been capturing investor attention due to its significant potential upside of..

Select Medical Holdings (SEM) Stock Analysis: 37.68% Potential Upside Beckons Investors

Select Medical Holdings Corporation (NYSE: SEM), a key player in the healthcare sector, specifically in the medical care facilities industry, presents a unique investment opportunity for those looking to capitalize..

Liquidia Corporation (LQDA) Stock Analysis: A Promising 132% Upside in the Biotech Arena

Liquidia Corporation (NASDAQ: LQDA), a key player in the biotechnology sector, has been capturing investor attention with its innovative approach to addressing unmet medical needs in the U.S. healthcare market...

Warby Parker Inc. (WRBY) Stock Analysis: Navigating Growth in the Competitive Eyewear Market

Warby Parker Inc. (NYSE: WRBY), a prominent player in the eyewear industry, is captivating investor attention with its innovative business model and steady revenue growth. The company, which operates in..

Edgewise Therapeutics, Inc. (EWTX): Unveiling a 175% Upside Potential in Biotech

Edgewise Therapeutics, Inc. (EWTX) is making waves in the biotechnology sector with its focus on innovative treatments for muscle disorders. With a market cap of $1.49 billion, the company is..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds